Latest Product Launch News

Elixinol Wellness reported a 10.8% revenue increase in Q2 2025, supported by improved cash receipts and a focused cost containment program. The company secured new funding and launched a menopause-targeted product, positioning itself for margin growth and profitability in H2.

Fintech Chain Limited reported a mixed quarter with strong customer receipts and new IoT SaaS product launch, while finalising its ASX delisting. The company’s cash position tightened amid loan repayments and rising operating costs.

Hydralyte USA reported an 8.5% rise in Q2 FY25 net sales, driven by strong May performance and improved margins, while preparing to launch new brain and gut health products.

FirstWave Cloud Technology reports a slight revenue decline in Q4 FY25, offsets challenges with strategic restructuring and a new AWS marketplace partnership.

HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.

One Click Group Limited reported a 28% revenue increase to $1.3 million in H1 2025, launched a new $500 cash advance product, and surpassed 200,000 registered users, setting the stage for further growth.

RMA Global Limited has reported its first full year of positive operating cash flow alongside accelerating revenue growth in both the US and ANZ markets, driven by strategic product launches and expanded brokerage partnerships.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

Jade Gas Holdings has activated its inaugural gas production wells at Mongolia’s Red Lake field, marking a pivotal step toward commercial coal bed methane output. The company also secured a A$3.6 million loan and is exploring a dual listing on the Hong Kong Stock Exchange to accelerate growth.

ReNerve Limited reported a robust 53% increase in annual revenue, driven by strategic partnerships and new regulatory approvals that broaden its global footprint in nerve repair.

Aspermont Limited reports a 7% revenue increase driven by subscription growth and a landmark contract with a top global mining company, while preparing to launch new data products.

Acrux Limited reports promising revenue growth driven by new topical generic launches in the US and secures crucial RDTI funding, marking a strategic shift under new CEO John Warmbrunn.